Children with pulmonary hypertension (PH) engage in fewer and shorter bouts of intense physical activity than their peers, according to a new study that measured data from sensors worn on the wrist. Moreover, kids with more severe PH generally had “worse physical testing,” as well as “a steeper decline…

Pulmonary hypertension (PH) is a serious and life-threatening disease. There was a time when the hardest part was simply staying alive, getting through each day, and not knowing what came next. But as my health has improved, the challenges have changed. The hardest part for me now isn’t survival.

The first participant has been enrolled in a two-part Phase 3 clinical trial testing IKT-001, Inhibikase Therapeutics’ experimental formulation of imatinib, in people with pulmonary arterial hypertension (PAH). The Phase 3 IMPROVE-PAH trial (NCT07365332) is expected to enroll nearly 500 adults with various forms of PAH, ages 18…